Screener
Eikon Therapeutics, Inc. EIKN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Marketable securities, current | 351,028 | 231,074 |
| Prepaid expenses and other current assets | 16,919 | 12,542 |
| Restricted cash | 400 | 400 |
| Total current assets | 529,501 | 348,917 |
| Property and equipment, net | 138,067 | 142,898 |
| Operating lease right-of-use assets, net | 91,066 | 90,965 |
| Marketable securities, non-current | 83,828 | — |
| Restricted cash, non-current | 7,808 | 7,771 |
Item 1. Condensed Financial Statements (Unaudited).
FAQ
- What is Eikon Therapeutics, Inc.'s total current assets?
- Eikon Therapeutics, Inc. (EIKN) reported total current assets of $529.5M in Q1 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Eikon Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude